Mariakerke, Belgium

Marc Anteunis

This inventor holds 5 USPTO granted patents. Top assignees: Solvay (Societe Anonyme), Solvay, Solvay & Cie (Societe Anonyme). Active years: 1988-2006.


% Patents Active = 80.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Gand, BE (1988)
  • Mariakerke, BE (1999 - 2006)

Company Filing History:


Years Active: 1988-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Marc Anteunis: A Visionary Inventor from Mariakerke, BE

Introduction:

Marc Anteunis is a visionary inventor hailing from Mariakerke, Belgium, with a profound passion for creating innovative solutions to complex problems. His remarkable creativity and dedication have made him a true pioneer in the realm of inventions.

Latest Patents:

Marc Anteunis holds a total of 5 patents, with his latest inventions revolving around the synthesis of ureins derived from α, ω-diamino acids. These ureins are meticulously crafted through a process that maintains exceptional chirality, showcasing his expertise in chemical engineering and precision.

Career Highlights:

Throughout his career, Marc Anteunis has made significant contributions to companies such as Solvay and Solvay & Cie. His inventive spirit and knack for problem-solving have led to groundbreaking discoveries that have pushed the boundaries of science and technology.

Collaborations:

Marc Anteunis has had the privilege of working closely with respected colleagues, including Roland Callens and Georges Blondeel. Their collaborative efforts have fueled innovation and fostered a dynamic environment where ideas flourish and inventions come to life.

Conclusion:

In conclusion, Marc Anteunis stands out as a visionary inventor whose pioneering work continues to inspire and shape the landscape of modern innovation. His dedication to pushing the boundaries of what is possible serves as a testament to his unwavering commitment to excellence in the field of inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…